Stansky Michael P, a director at TriSalus Life Sciences Inc. ($TLSI), made two open market purchases of common shares worth $1.5 million over the past year. His most recent buy occurred on February 23, 2026. These purchases rank him 393rd among nearly 5,000 insiders by total amount bought, above the average of $1.5 million across about 3.3 transactions per insider. He reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Stansky Michael P | Director | P | Common Stock | 243900 | $4.10 | 986,830.0000 | 49,964,311 | 32.83% | 0.49% |
| Feb. 23, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Stansky Michael P | Director | P | Common Stock | 117198 | $4.10 | 986,830.0000 | 49,964,311 | 13.48% | 0.23% |
| Feb. 4, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Stansky Michael P | Director | A | Director Stock Option (right to buy) | 92537 | $0.00 | 92,537.0000 | 49,964,311 | 9999.99% | 0.19% |